Stay updated on Pembrolizumab & Cetuximab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study’s Conditions list now includes squamous cell carcinoma of the head and neck and nasal cavity/paranasal sinus carcinoma.
    Difference
    0.1%
    Check dated 2026-04-02T15:32:23.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T04:56:38.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    - Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:55:25.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Hypopharynx cancer and Oropharynx cancer were added to the Conditions list, and a Genetic and Rare Diseases Information Center resource was added under Resources.
    Difference
    0.2%
    Check dated 2026-02-25T18:37:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added site revision note: Revision v3.4.2. Removed older notices (Revision v3.4.1) and the funding-status message; no trial data or core page content was altered.
    Difference
    0.4%
    Check dated 2026-02-11T14:13:04.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The study status was updated to Completed with revised completion and enrollment details, and a government funding/operating-status notice was added.
    Difference
    0.8%
    Check dated 2026-02-04T10:18:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Cetuximab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.